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ABSTRACT
Despite recent advances in antibiotic therapy, sepsis remains a major clinical challenge in
intensive care units. Here we examined the anti-inflammatory and antioxidant effects of
Ecballium elaterium (EE) on brain, and explored its therapeutic potential in an animal
model of sepsis-associated encephalopathy (SAE) [induced by cecal ligation and puncture
(CLP)].
Thirty rats were divided into three groups of 10 each: control, sepsis, and treatment. Rats
were subjected to CLP except for the control group, which underwent laparatomy only. The
treatment group received 2.5 mg/kg EE while the sepsis group was administered by saline.
Twenty-four hours after laparotomy, animals were sacrificied and the brains were removed.
Brain homogenates were prepared to assess interleukin 1beta (IL-1β), interleukin 6 (IL-6),
tumor necrosis factor alpha (TNF-α), total antioxidant capacity (TAC), and total oxidant status
(TOS). Brain tissue sections were stained by hematoxylin and eosin (H&E) to semi-quantita-
tively examine the histopathologic changes such as neuron degeneration, pericellular/peri-
vascular edema and inflammatory cell infiltration in the cerebral cortex.
We found a statistically significant reduction in brain tissue homogenate levels of TNF-α
59.5 ± 8.4/50.2 ± 6.2 (p = 0.007) and TOS 99.3 ± 16.9/82.3 ± 7.8 (p = 0.01) in rats treated with
EE; although interleukin 6 levels were increased in the treatment group compared to the
sepsis group, this was not statistically significant. Neuronal damage (p = 0.00), pericellular/
perivascular edema and inflammatory cell infiltration (p = 0.001) were also significantly lower
in the treatment group compared to those in the sepsis group.
These data suggest that Ecballium elaterium contains some components that exert
protective effects against SAE in part by attenuating accumulation of proinflammatory
cytokines, which may be important contributors to its anti-inflammatory effects during sepsis.
ARTICLE HISTORY
Received 18 February 2017









elaterium; Sepsis; TNF-α; TOS
1. Introduction
Sepsis remains a major cause of morbidity andmortality
despite recent advances in new treatments and rapidly
evolving technologies that are being exploited to
improve organ dysfunctions [1]. Sepsis is a systemic
inflammatory response that may extend to involvement
of widespread cell and tissue damage remote from the
localized site of infection. During sepsis, brain is one of
the first organs affected and up to 71% of patients
demonstrate encephalopathy [1,2]. Sepsis associated
encephalopathy (SAE) is the most common encephalo-
pathy encountered among intensive care unit (ICU)
patients and has been usually associated with poor
prognosis [3,4]. SAE may cause serious cognitive dys-
functions, impaired consciousness, and delirium [5].
Polymicrobial sepsis induced by cecal ligation and
puncture (CLP) is the most frequently used model
among researchers since it closely resembles the char-
acteristics of human sepsis [6]. It has been accepted as a
gold standard model for sepsis and SAE [7]. This model
may show central nervous system involvement as well
as hepatic, pulmonary and renal dysfunctions [5].
Ecballium elaterium (EE) is a plant from the
Cucurbitacea family growing in the Mediterrenian
region of Turkey. It has been used in traditional
Anatolian medicine for rhinosinusitis treatment due
to its topical anti-inflammatory properties. These
properties were widely studied by Uslu et al. [8,9].
Here, in our study, we wanted to further explore its
anti-inflammatory effects and to determine if EE has
neuroprotective potential during SAE.
2. Material and methods
2.1. Plant materials
Ecballium elaterium plant was picked from the Izmir
forests in Turkey. The plant extract was prepared
according to the method described by Okur et al. [10].
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2.2. Anesthesia and surgical procedures
This study was approved by the Ethics Committee of
Animal Experimentation of Dicle University School of
Medicine. The animals were cared for according to the
principles of the Guide for Care and Use of
Experimental Animals.
We used 30 male Wistar albino rats, weighing
260–290 g, in this study. The rats were kept in cages
under controlled conditions of temperature (21 ± 1°C),
light (12 h light/12 h dark cycle) and relative humidity (%
40–70). They were fed a balanced pellet diet and water,
and acclimatized to conditions for one week before use.
Intramuscular injection of 50 mg/kg ketamine
hydrochloride (Ketalar; Eczacibasi, Istanbul, Turkey)
and 10 mg/kg xylazine (Rompun; Bayer, Istanbul,
Turkey) was used for surgical anesthesia in all ani-
mal groups. Anesthesia was repeated as required
during the surgical procedure. Animals underwent
surgery under aseptic conditions. No antibiotics
were administered during the experiment. A 3-cm
midline incision was made on the abdominal wall,
followed by ileocecal valve ligation with 3-O silk
suture. Using a 18-gauge needle, antimesenteric sur-
face of the cecum was punctured once. A piece of
stool was extruded from the cecal enterotomy.
Finally, the cecum was returned to the intraperito-
neal cavity and the abdominal wall closed in layers
of peritoneum and skin using running 3-O silk
suture.
2.3. Animal groups and study design
Thirty rats were randomly divided into three groups:
control group (n = 10), sepsis group (n = 10), treat-
ment group (n = 10). Rats in the control group under-
went sham laparotomy only, while sepsis and
treatment groups were subjected to CLP after lapar-
otomy; 2.5 mg/kg Ecballium elaterium extract and 2
cc saline were administered intraperitoneally (treat-
ment group and sepsis group, respectively) as pre-
viously reported [10,11] and then incisions were
closed by proper suturing of the peritoneum and
skin layers. At post-operative 24 h, the animals were
sacrificied and the brains were removed. Brain homo-
genates and tissue sections were prepared for bio-
chemical and histological examinations.
2.4. Assesment of IL-1β, IL-6, TNF-α, TAC, and
TOS levels in brain tissue
Tissues were stored at −80°C and then were thawed
by stepwise temperature increase (–20 °C and +4°C,
respectively). Phosphate tampon with pH 7.4
andWiseTis homogenizer were used for tissue homo-
genization. The homogenate was then subjected to
centrifugation at 3000 rpm for 10 min at +4°C.
Supernatant was then transferred to ependorf tubes
and IL-1β, IL-6, TNF-α levels were studied according to
the ELISA kit procedure (eBioscience, Austria). Total
antioxidant capacity (TAC) and total oxidant status
(TOS) were measured by Erel’s methods [12,13].
2.5. Histologic analysis
Brain tissues were fixed by 10% formalin and then
embedded in paraffin; 4 μm- thin sections were pre-
pared and then stained by hematoxylin and eosin
(H&E). Three sections from each animal were taken
and three microscopic areas (cerebral cortex, basal
ganglion, and cerebellum) in each section were exam-
ined. Histopathologic changes were observed under a
light microscope by a pathologist blinded to the three
study groups. Neuron degeneration, pericellular/peri-
vascular edema and inflammatory cell infiltration were
semiquantitatively examined in the cerebral cortex.
Pycnotic nucleus, perineural space expansion and
swelling or shrinkage of the cell were accepted as
neuron degeneration and scored on a scale of 0–3
(0: no injury, 1: 1–3 cells/region 2: 4–6 cells/region, 3:
7–10 cells/region). Pericellular /perivascular edema
and inflammatory cell infiltration was scored as 0: no
injury, 1: slight injury, 2: moderate injury, 3: severe
injury.
2.6. Statistical analysis
Data were analyzed using IBM SPSS statistics for
Windows 18.0. Continuous variables were reported
as mean ± standard deviation and median ± mini-
mum-maximum. Descriptive statistics were used as
continuous variables. Mann-Whitney U-test with
Bonferroni correction and the Kruskal-Wallis test
were used to compare differences between the
groups within a categorical value. p values of <0.017
were considered statistically significant.
3. Results
3.1. Biochemical results for brain tissues
Sepsis group was compared with the controls. The
brain tissue levels of TNF-α (p = 0.003) and TAC
(p = 0.004) were significantly higher in the sepsis
group compared to those of control group.
However, there was no statistical difference detected
in IL-1 β, IL-6 and TOS levels between these groups.
Sepsis group was further compared with the treat-
ment group. The brain tissue levels of TNF-α (p = 0.007)
and TOS (p = 0.01) decreased significantly in the treat-
ment group compared to the sepsis group. No statistical
difference was detected between IL-1 β, IL-6 and TAC
levels of these two groups (Tables 1 and 2).































Neuronal damage (p = 0.002, p = 0.00), pericellular/
perivascular edema and inflammatory cell infiltration
(p = 0.003, p = 0.001) were higher in the sepsis group
compared to those in control and treatment groups,
respectively (Figure 1, Table 3).
4. Discussion
Sepsis is a major clinical challenge in intensive care
units [14]. It is a potentially life threatening condition
complicated with important biochemical and histolo-
gic changes occurring especially within six hours [3].
The understanding of underlying mechanisms of sep-
sis has been improving [15]. Inflammatory response,
which is induced by sepsis, may cause serious organ
dysfunctions where endothelial injury plays a pivotal
role [16]. As well as being a gatekeeper between
blood and tissues, endothelium also exerts many
functions in anti-inflammatory and anti-oxidant
defense. Bacterial toxins and oxidative stress disturb
endothelial integrity [15,16].This results in incresed
permeability of the blood-brain barrier and brain
Table 1. Biochemical analysis of brain tissue in different groups.
IL-1β ± sd IL-6±sd TNF-α ± sd TAC ± sd TOS ± sd
pg/L pg/mL ng/L mmol/L μmol/L
CG 392.9 ± 12.5 31.7 ± 2.2 51.9 ± 2.4 0.1 ± 0.06 116.4 ± 11.6
SG 403.5 ± 35.0 29.9 ± 1.2 59.5 ± 8.4 0.2 ± 0.03 99.3 ± 16.9
TG 374.7 ± 37.5 36.8 ± 9.5 50.2 ± 6.2 0.2 ± 0.09 82.3 ± 7.8
pa 0.796 0.06 0.003 0.004 0.034
pb 0.08 0.02 0.007 0.21 0.01
CG: control group; SG: sepsis group; TG: treatment group; pa: comparison of CG and SG; pb; comparison of SG and TG.
Table 2. Biochemical analysis of brain tissue in different groups. Median (min-max).
IL-1β pg/L IL-6 pg/mL TNF-α ng/L TAC mmol/L TOS μmol/L
CG 396,9 (371,6–403,7) 31,2 (29,6–34,6) 52,8 (47,8–54,6) 0,12 (0,02–0,23) 113,6 (101,5–134,9)
SG 394,5 (349,6–498,4) 29,8 (27,8–31,9) 55,7 (52,8–75,0) 0,22 (0,14–0,25) 95,2 (76,2–127,6)
TG 377,7 (327,3–431,2) 34,4 (27,6–54,6) 49,3 (38,3–61,1) 0,28 (0,13–0,43) 83,7 (72,03–95,7)
pa 0.796 0.06 0.003 0.004 0.034
pb 0.08 0.02 0.007 0.21 0.01
CG: control group; SG: sepsis group; TG: treatment group.
Figure 1. Light microscopy of brain tissues in different groups [hematoxylin and eosin (H&E), magnification 200×]. (a) Normal
cerebral cortex (control group). (b) Pyknosis, degeneration at the capillary vessels, perineural and perivascular edema (sepsis
group). (c) perineural and perivascular mild/moderate edema (treatment group).






























edema, which may distort microcirculation. Further
production of reactive oxygen species (ROS) through
the brain tissues may induce increased secretion of
pro-inflammatory cytokines such as IL-1 β, IL-6 ve
TNF-α [17,18]. This extreme inflammatory response
produces oxidative tissue damage and affects brain
functions as well. Although it is known that sepsis
may cause encephalopathy via distant organ damage
such as seen in liver and kidney, it is also possible to
see encephalopathy without any distant organ
damage. This may support the idea of SAE resulting
from the systemic inflammation related to sepsis [4,7].
It is well-known that interleukin 6 plays an impor-
tant role in diagnosis and prediction of mortality of
patients with sepsis [18,19]. Most sepsis studies are
based on serum interleukin 6 levels. In this study, we
measured the levels of interleukin 6 in brain tissue.
Goncalves at al. studied the profile of inflammatory
markers in different tissues in experimental sepsis
[20]. Their study showed that the changes of inflam-
matory marker levels in different tissues were not
following a similar pattern at similar time-points
although the serum levels were high at all time-
points. Also, they reported that interleukin 6 levels in
brain tissue are not significantly changed after 24 h. In
the literature, TNF-alpha was commonly measured as
a marker for sepsis associated encephalopathy in the
brain tissue. The interleukin 6 levels were measured in
serum [1,19,21–24].
TNF-α is secreted by many cells in brain tissues. It has
protective and modulatory functions in normal brain
tissues while showing neurotoxic effects during patho-
logic changes in the brain. It has a key role during
immune response and may cause inflammation, apop-
tosis and necrosis [25]. It has been shown that peripheral
and central administration of some pro-inflammatory
cytokines may induce behavioral changes [26]. Erbas
et al. detected a positive correlation between TNF-α
levels and stereotype scores in septic rats. Their study
further clarified the role of TNF-α and oxidative stress in
behavioral changes [27]. In a similar manner, TNF-αmay
have an important role in SAE pathophysiology. Here, in
our study, the sepsis group was found to have a signifi-
cant increase in brain tissue levels of TNF-α while the
rats treated with Ecballium elaterium had a significant
reduction. EE might cause this decrease in TNF-α levels
by its anti-inflammatory effects.
Although SAE pathopysiology is not well under-
stood, many signs such as changes in the blood-
brain barrier and cerebral blood flow, cerebral
edema, inflammation, oxidative stress, mitochondrial
dysfunction, distortion in microcirculation and apop-
tosis were shown in different animal models [28]. An
increase in apoptosis in lung, liver, kidney and intes-
tine was detected in experimental sepsis models and
found to be directly proportional to serum TNF-α
levels [29]. TNF-α increases neuronal apoptosis and
brain edema by stimulating neutrophil infiltration in
the brain tissue. It has been shown that TNF-α is
related to aquaporin 4 receptor up-regulation and
cerebral edema, and has a key role in SAE [21].
Long-term memory deficit and neuronal loss was
seen in experimental models, similar to signs in
patients with sepsis [30]. Our study also showed
higher neuronal damage, pericellular/perivascular
edema and inflammatory cell infiltration score in the
sepsis group. This score was significantly lowered in
the treatment group, which might explain the protec-
tive effects of Ecballium elaterium on brain dur-
ing SAE.
The complexities of the septic cascade continue to
emerge and may identify new targets for innovative
patient management. Current conventional sepsis
treatments may worsen endothelial damage.
Antibiotics may increase proinflammatory cytokine
secretions and may further cause organ deficiencies.
Fluid resuscitation, if delayed, may not improve the
microcirculation disturbances, or if given too much,
may distort barrier function. Taken together anti-oxi-
dant agents are important candidates in sepsis treat-
ment since they protect endothelial integrity [17].
Ecballium elaterium (EE) is a wild plant, which
grows in the Mediterranean region and has been
used in traditional medicine for many centuries.
Some studies have described its cytotoxic effects
against cancer cells as well as its neuroprotective
and hepatoprotective roles [8,11,30]. The core of the
EE fruit contains black seeds and a liquid juice. EE
extract is made from this juice, which is also called
‘elaterium’. This juice, without dilution, may cause
edema formation if used topically [31]. However,
Yesilada et al. determined EE’s anti-edema activity by
decreasing vascular permeability [32]. Also, our study
did not show any edema formation due to EE but
rather its protective effects against brain edema.
There is no previous study that determined the
effects of EE on brain in a sepsis model. Our study is
the first to reveal its effects in SAE, yet it has consider-
able importance from this perspective. Here, in this
study, we explored the underlying mechanisms of EE’s
anti-oxidant and anti-inflammatory effects and deter-
mined that EE decreases oxidative damage induced
by sepsis. TAC levels were increased in the sepsis
group as opposed to decreased TOS levels in inverse
proportion. This may explain that anti-oxidant activity
was enhanced in order to suppress oxidant activity.
Table 3. Brain histopathology results.
CG SG TG pa pb
Neuronal damage ± sd 0.00 2.3 ± 0.4 0.00 0.002 0.00
Edema and inflammatory
cell infiltration ± sd
0.00 2.6 ± 0.5 1.2 ± 0.4 0.003 0.001
CG: control group; SG: sepsis group; TG: treatment group; pa: compar-
ison of CG and SG; pb: comparison of SG and TG.






























Furthermore, in the treatment group, EE also sup-
pressed oxidant activity due to a significant decrease
in TOS levels.
There is a limitation of the current study: The brains
of 10 rats were divided into two hemispheres. The first
hemisphere was used for homogenate studies. The
second hemisphere was used for histological examina-
tion. Kafa at al. reported that sepsis affects each part of
the brain differently but affects bilateral hemispheres
equally. Because of this,, we used this technique to
prevent errors resulting from different responses from
different parts of the brain to the sepsis [33].
5. Conclusions
We suggest that EE reduces the detrimental effects of
sepsis on brain by its anti-inflammatory and anti-oxi-
dant functions. Ecballium elaterium contains some
components that exert protective effects against SAE
in part by attenuating accumulation of proinflamma-
tory cytokines. Decreased TNF-α and TOS levels, while
correlated with the histopathologic results, show
strong evidence that EE might be beneficial in neuro-
protection during sepsis with all these potential
effects. However, further studies with larger numbers
of animals, different dosages of medications, and
measurements of cytokines and oxidative parameters
and also more detailed examination of the chemical
composition of these extracts, are needed to clarify
the neuroprotective role of EE in sepsis.
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